Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · Real-Time Price · USD
0.630
+0.010 (1.61%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cyclo Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.87 | 1.08 | 1.38 | 1.59 | 0.9 | 1.01 | Upgrade
|
| Revenue Growth (YoY) | -8.52% | -21.76% | -13.24% | 75.54% | -10.31% | -0.42% | Upgrade
|
| Cost of Revenue | 0.08 | 0.1 | 0.15 | 0.17 | 0.07 | 0.24 | Upgrade
|
| Gross Profit | 0.79 | 0.98 | 1.23 | 1.42 | 0.83 | 0.77 | Upgrade
|
| Selling, General & Admin | 9.49 | 6.83 | 7.82 | 6.52 | 3.68 | 3.44 | Upgrade
|
| Research & Development | 15.97 | 14.18 | 9 | 9.15 | 6.1 | 4.87 | Upgrade
|
| Operating Expenses | 25.47 | 21.03 | 16.85 | 15.71 | 9.79 | 8.31 | Upgrade
|
| Operating Income | -24.68 | -20.05 | -15.62 | -14.29 | -8.96 | -7.54 | Upgrade
|
| Interest & Investment Income | 0.59 | - | 0.01 | 0 | 0.02 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | -22.61 | -20.05 | -15.61 | -14.29 | -8.94 | -7.53 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0 | -0.01 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | -2.18 | - | 0.16 | - | - | - | Upgrade
|
| Pretax Income | -24.8 | -20.06 | -15.45 | -14.29 | -8.94 | -7.53 | Upgrade
|
| Net Income | -24.8 | -20.06 | -15.45 | -14.29 | -8.94 | -7.53 | Upgrade
|
| Net Income to Common | -24.8 | -20.06 | -15.45 | -14.29 | -8.94 | -7.53 | Upgrade
|
| Shares Outstanding (Basic) | 27 | 16 | 8 | 6 | 2 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 27 | 16 | 8 | 6 | 2 | 1 | Upgrade
|
| Shares Change (YoY) | 109.38% | 93.50% | 32.48% | 298.32% | 47.81% | 32.33% | Upgrade
|
| EPS (Basic) | -0.92 | -1.23 | -1.83 | -2.24 | -5.59 | -6.96 | Upgrade
|
| EPS (Diluted) | -0.92 | -1.23 | -1.83 | -2.24 | -5.59 | -6.96 | Upgrade
|
| Free Cash Flow | -22.52 | -16.19 | -15.13 | -15.03 | -8.59 | -6.59 | Upgrade
|
| Free Cash Flow Per Share | -0.83 | -0.99 | -1.79 | -2.36 | -5.37 | -6.09 | Upgrade
|
| Gross Margin | 91.24% | 90.85% | 89.10% | 89.48% | 91.85% | 76.41% | Upgrade
|
| Operating Margin | -2834.06% | -1862.69% | -1135.51% | -901.15% | -991.99% | -749.06% | Upgrade
|
| Profit Margin | -2848.16% | -1863.36% | -1123.08% | -900.94% | -989.80% | -747.87% | Upgrade
|
| Free Cash Flow Margin | -2586.35% | -1503.84% | -1099.71% | -947.67% | -951.24% | -654.37% | Upgrade
|
| EBITDA | -24.67 | -20.03 | -15.6 | -14.27 | -8.95 | -7.54 | Upgrade
|
| D&A For EBITDA | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
| EBIT | -24.68 | -20.05 | -15.62 | -14.29 | -8.96 | -7.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.